Department of Health – Abu Dhabi, M42 and AbbVie enter a strategic partnership to advance personalised medicine and genomics
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has signed a Memorandum of Understanding (MoU) with AbbVie Biopharmaceutical and M42 to elevate collaborative efforts in tailoring personalised medicine and genomics in Abu Dhabi, the capital of the United Arab Emirates (UAE). M42 is a first-of-its-kind, tech-enabled, integrated healthcare company created through the coming together of G42 Healthcare and Mubadala Health.